The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.375
Bid: 1.30
Ask: 1.45
Change: -0.025 (-1.79%)
Spread: 0.15 (11.538%)
Open: 1.40
High: 1.40
Low: 1.30
Prev. Close: 1.40
XSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Terms of Warrants Consultation and Trading Update

29 Nov 2023 07:00

RNS Number : 9729U
Xeros Technology Group plc
29 November 2023
 

29 November 2023

 

This announcement contains inside information

 

Xeros Technology Group plc

('Xeros", the "Company" or the "Group")

 

Consultation on Amendment to Terms of Warrants and Trading Update

 

Xeros Technology Group plc (AIM: XSG), the creator of technologies that reduce the impact of clothing on the planet, today provides an update on outstanding Warrants and an update on trading to date in the full year to 31 December 2023 ("FY23" or "Period").

 

Warrants

 

There are currently in issue 127,192,846 Warrants to subscribe for ordinary shares, which were issued in October 2022 as part of the fundraise undertaken by the Company at that time. These Warrants can be exercised at a price of 5p and are due to lapse on 21 April 2024. Following requests from certain Warrant holders, the Board is currently exploring the possibility of amending the terms of these Warrants with a view to bringing additional capital into the business in the near-term in a cost-effective manner. Further announcements will be made following the Board's review.

 

Trading update

 

Adjusted EBITDA1 for FY23 is expected to be in line with market expectations2 as a result of continued focus on cost control. The revenue for the Period is dependent on the timing of a specific XOrb shipment delivery date to one of the Group's licence partners. The final timing of this delivery, either during FY23 or post Period-end will determine whether or not FY23 revenue will be in line with market expectations. Delivery of this order during FY23 would see the Group's performance ahead of expectations at the Adjusted EBITDA level.

 

The Group anticipates that the year-end cash balance will be in line with market expectations2, subject to the timely receipt of an R&D tax credit payment of approximately £0.5m from HMRC, which is anticipated to be received before the year end.

 

Neil Austin, CEO said:

 

"We are delighted that the business continues to perform as expected. We would also to thank our shareholders for their continuing and proactive support, in what is an important year in Xeros' transition to break-even."

 

1

Adjusted EBITDA losses are defined as the loss on ordinary activities before interest, tax, share-based payment expense, warrant expense, depreciation and amortisation.

2

For the purpose of this announcement, the Board believes market expectations for FY23 to be Revenue of £0.8m, Adjusted EBITDA loss of £4.7 million and a year-end cash balance of £1.6 million.

 

Enquiries

 

Xeros Technology Group plc

Neil Austin, Chief Executive Officer

Alex Tristram, Director of Finance

 

Tel: 0114 269 9656

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Julian Blunt/Teddy Whiley, Corporate Finance

Andrew Burdis/Sunila de Silva, ECM

 

Tel: 020 7220 0570

Belvedere PR

Cat Valentine

Keeley Clarke

xeros@belvederepr.com

Mob: 07715 769 078

Mob: 07967 816 525

 

 

About Xeros

 

Xeros Technology plc has developed patented and proven, industry-leading technologies which reduce the environmental impact of how industries make and care for clothes.

 

The traditional wet processing methods used in industrial and domestic laundry and garment manufacturing consume billions of litres of fresh water and large amounts of energy and chemicals, as well as damaging and weakening clothing fibres and creating rising levels of environmental pollution. It is estimated that washing machines contribute 35% of the 171 trillion microplastic particles in the ocean.

 

A range of actors, including consumers, the media NGOs and regulators are exerting pressure on these industries, with legislative action beginning to be taken.

 

Xeros' three main technologies, Filtration, Finish, and Care, facilitate garment manufacturers, industrial laundries, domestic washing machine manufacturers and consumers, to reduce their environmental impact, whilst also significantly improving efficiency in the process.

 

Xeros' model is to generate revenue from licensing its technologies, generating royalties and the sale of consumables. Currently there are 8 agreements in place. The addressable markets in Filtration, Finish and Care are estimated to be valued at £350m p.a., £132m p.a. and £3bn p.a. respectively.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZMZMRRLGFZM
Date   Source Headline
26th Apr 20245:01 pmRNSTR-1
26th Apr 202412:09 pmRNSTR-1
25th Apr 20242:09 pmRNSResult of GM, Director Dealings and TVR
19th Apr 20241:13 pmRNSResult of Retail Offer
9th Apr 20242:58 pmRNSTR-1
8th Apr 20244:30 pmRNSPosting of Circular and Notice of General Meeting
8th Apr 20243:56 pmRNSTR-1
5th Apr 202410:22 amRNSTotal Voting Rights
4th Apr 20246:29 pmRNSResult of Fundraising
4th Apr 20244:49 pmRNSRetail Offer
4th Apr 20244:40 pmRNSFundraising to raise up to £5.5 million
11th Mar 20247:00 amRNSAlex Tristram joins the Board as Finance Director
8th Feb 20245:03 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSHolding(s) in Company
8th Feb 20242:51 pmRNSHolding(s) in Company
8th Feb 20249:07 amRNSHolding(s) in Company
7th Feb 20242:05 pmRNSHolding(s) in Company
6th Feb 20243:24 pmRNSHolding(s) in Company
6th Feb 202410:22 amRNSHolding(s) in Company
5th Feb 20247:00 amRNSTR-1
2nd Feb 20247:00 amRNSExercise of Warrants, Issue of Equity and TVR
29th Jan 202412:00 pmRNSHolding(s) in Company
26th Jan 20241:35 pmRNSExercise of Warrants and Total Voting Rights
19th Jan 20243:31 pmRNSExercise of warrants and Total Voting Rights
18th Jan 20242:37 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSDirector/PDMR Shareholding
17th Jan 20242:22 pmRNSHolding(s) in Company
16th Jan 20244:38 pmRNSHolding(s) in Company
15th Jan 20245:32 pmRNSHolding(s) in Company
9th Jan 20242:33 pmRNSHolding(s) in Company
8th Jan 20246:00 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSHolding(s) in Company
2nd Jan 20241:56 pmRNSBlock listing Interim Review
21st Dec 20231:38 pmRNSResults of Warrant Holder Meeting
15th Dec 202311:55 amRNSHolding(s) in Company
4th Dec 20237:00 amRNSCircular Posting & Warrant Holder Meeting Notice
29th Nov 20237:00 amRNSTerms of Warrants Consultation and Trading Update
20th Nov 20233:45 pmRNSHolding(s) in Company
14th Nov 20235:01 pmRNSHolding(s) in Company
8th Nov 20233:29 pmRNSHolding(s) in Company
3rd Nov 20233:11 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNS2023 Interim Results
18th Sep 20237:00 amRNSChange of Auditor
12th Sep 202311:17 amRNSNotice of Results and Online Presentations
4th Jul 20231:05 pmRNSSix Monthly Block Listing Review
23rd May 20231:50 pmRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSMello2023 Investor Conference
17th May 20237:00 amRNSSecond Denim Finishing Licensing Agreement
28th Apr 20237:00 amRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.